View in EDS PDF Full Text

Germline polymorphisms in MGMT associated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825.

Saved in:
Bibliographic Details
Title: Germline polymorphisms in MGMT associated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825.
Authors: Scheurer ME; Baylor College of Medicine, Departments of Pediatrics and Medicine, Houston, Texas, USA., Zhou R; Baylor College of Medicine, Departments of Pediatrics and Medicine, Houston, Texas, USA., Gilbert MR; National Institutes of Health Clinical Center, Bethesda, MD, USA., Bondy ML; Baylor College of Medicine, Departments of Pediatrics and Medicine, Houston, Texas, USA., Sulman EP; M D Anderson Cancer Center, Brain and Spine Center, Houston, TX, USA.; Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, NY, USA., Yuan Y; M D Anderson Cancer Center, Brain and Spine Center, Houston, TX, USA., Liu Y; Baylor College of Medicine, Departments of Pediatrics and Medicine, Houston, Texas, USA., Vera E; National Institutes of Health Clinical Center, Bethesda, MD, USA.; M D Anderson Cancer Center, Brain and Spine Center, Houston, TX, USA., Wendland MM; National Cancer Institute, Bethesda, MD, USA.; Texas Oncology Cancer Center Sugar Land, Sugar Land, TX, USA., Youssef EF; Arizona Oncology Services Foundation, Tucson, AZ, USA., Stieber VW; Forsyth Regional Cancer Center, Winston-Salem, NC, USA., Komaki RR; M D Anderson Cancer Center, Brain and Spine Center, Houston, TX, USA., Flickinger JC; UPMC-Shadyside Hospital, Pittsburgh, PA, USA., Kenyon LC; Thomas Jefferson University Hospital, Philadelphia, PA, USA., Robins HI; University of Wisconsin Hospital, Madison, WI, USA., Hunter GK; Intermountain Medical Center, Murray, UT, USA., Crocker IR; Emory University, Winship Cancer Institute, Atlanta, GA, USA., Chao ST; Cleveland Clinic Foundation, Cleveland, OH, USA., Pugh SL; NRG Oncology Statistics and Data Management Center, Philadelphia, PA, USA., Armstrong TS; National Institutes of Health Clinical Center, Bethesda, MD, USA.
Source: Neuro-oncology advances [Neurooncol Adv] 2022 Oct 22; Vol. 4 (1), pp. vdac152. Date of Electronic Publication: 2022 Oct 22 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101755003 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-2498 (Electronic) Linking ISSN: 26322498 NLM ISO Abbreviation: Neurooncol Adv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36299794
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Germline polymorphisms in MGMT associated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Scheurer+ME%22">Scheurer ME</searchLink>; Baylor College of Medicine, Departments of Pediatrics and Medicine, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Zhou+R%22">Zhou R</searchLink>; Baylor College of Medicine, Departments of Pediatrics and Medicine, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Gilbert+MR%22">Gilbert MR</searchLink>; National Institutes of Health Clinical Center, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Bondy+ML%22">Bondy ML</searchLink>; Baylor College of Medicine, Departments of Pediatrics and Medicine, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Sulman+EP%22">Sulman EP</searchLink>; M D Anderson Cancer Center, Brain and Spine Center, Houston, TX, USA.; Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Yuan+Y%22">Yuan Y</searchLink>; M D Anderson Cancer Center, Brain and Spine Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Liu+Y%22">Liu Y</searchLink>; Baylor College of Medicine, Departments of Pediatrics and Medicine, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Vera+E%22">Vera E</searchLink>; National Institutes of Health Clinical Center, Bethesda, MD, USA.; M D Anderson Cancer Center, Brain and Spine Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Wendland+MM%22">Wendland MM</searchLink>; National Cancer Institute, Bethesda, MD, USA.; Texas Oncology Cancer Center Sugar Land, Sugar Land, TX, USA.<br /><searchLink fieldCode="AU" term="%22Youssef+EF%22">Youssef EF</searchLink>; Arizona Oncology Services Foundation, Tucson, AZ, USA.<br /><searchLink fieldCode="AU" term="%22Stieber+VW%22">Stieber VW</searchLink>; Forsyth Regional Cancer Center, Winston-Salem, NC, USA.<br /><searchLink fieldCode="AU" term="%22Komaki+RR%22">Komaki RR</searchLink>; M D Anderson Cancer Center, Brain and Spine Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Flickinger+JC%22">Flickinger JC</searchLink>; UPMC-Shadyside Hospital, Pittsburgh, PA, USA.<br /><searchLink fieldCode="AU" term="%22Kenyon+LC%22">Kenyon LC</searchLink>; Thomas Jefferson University Hospital, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Robins+HI%22">Robins HI</searchLink>; University of Wisconsin Hospital, Madison, WI, USA.<br /><searchLink fieldCode="AU" term="%22Hunter+GK%22">Hunter GK</searchLink>; Intermountain Medical Center, Murray, UT, USA.<br /><searchLink fieldCode="AU" term="%22Crocker+IR%22">Crocker IR</searchLink>; Emory University, Winship Cancer Institute, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Chao+ST%22">Chao ST</searchLink>; Cleveland Clinic Foundation, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Pugh+SL%22">Pugh SL</searchLink>; NRG Oncology Statistics and Data Management Center, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Armstrong+TS%22">Armstrong TS</searchLink>; National Institutes of Health Clinical Center, Bethesda, MD, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101755003%22">Neuro-oncology advances</searchLink> [Neurooncol Adv] 2022 Oct 22; Vol. 4 (1), pp. vdac152. <i>Date of Electronic Publication: </i>2022 Oct 22 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101755003 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2632-2498 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226322498%22">26322498 </searchLink><i>NLM ISO Abbreviation: </i>Neurooncol Adv <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36299794
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/noajnl/vdac152
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: vdac152
    Titles:
      – TitleFull: Germline polymorphisms in MGMT associated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Scheurer ME
      – PersonEntity:
          Name:
            NameFull: Zhou R
      – PersonEntity:
          Name:
            NameFull: Gilbert MR
      – PersonEntity:
          Name:
            NameFull: Bondy ML
      – PersonEntity:
          Name:
            NameFull: Sulman EP
      – PersonEntity:
          Name:
            NameFull: Yuan Y
      – PersonEntity:
          Name:
            NameFull: Liu Y
      – PersonEntity:
          Name:
            NameFull: Vera E
      – PersonEntity:
          Name:
            NameFull: Wendland MM
      – PersonEntity:
          Name:
            NameFull: Youssef EF
      – PersonEntity:
          Name:
            NameFull: Stieber VW
      – PersonEntity:
          Name:
            NameFull: Komaki RR
      – PersonEntity:
          Name:
            NameFull: Flickinger JC
      – PersonEntity:
          Name:
            NameFull: Kenyon LC
      – PersonEntity:
          Name:
            NameFull: Robins HI
      – PersonEntity:
          Name:
            NameFull: Hunter GK
      – PersonEntity:
          Name:
            NameFull: Crocker IR
      – PersonEntity:
          Name:
            NameFull: Chao ST
      – PersonEntity:
          Name:
            NameFull: Pugh SL
      – PersonEntity:
          Name:
            NameFull: Armstrong TS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 22
              M: 10
              Text: 2022 Oct 22
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2632-2498
          Numbering:
            – Type: volume
              Value: 4
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Neuro-oncology advances
              Type: main
ResultId 1